Dr. Drenser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1135 W University Dr
Ste 330
Rochester, MI 48307Phone+1 248-652-7400Fax+1 248-652-7589- Is this information wrong?
Summary
- Dr. Drenser has had a distinguished academic career, having received a Ph.D. in Molecular Genetics & Microbiology in addition to her medical degree from the University of Florida, Gainesville. She completed her post-doctoral work at UC San Francisco in 1999, and has received numerous academic honors and awards. She has been with Associated Retinal Consultants since completion of her fellowship in 2005.
Dr. Drenser’s special interest is in translating laboratory science into practical treatments for retinal diseases. She established and serves as Director of the Pediatric Retinal Disease Molecular Genetics Laboratory on the Royal Oak campus. She has authored co-authored a number of peer-reviewed publications and book chapters, and has spoken at numerous national and international ophthalmologic meetings.
Dr. Drenser is a member of the American Academy of Ophthalmology, American Medical Association and the Association in Research of Vision and Ophthalmology.
Clinical Expertise
- Reitnal disease
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Ophthalmology, 2000 - 2003
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 1999 - 2000
- University of Florida College of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2001 - Present
- MI State Medical License 2003 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- Mechanisms Underlying Rare Inherited Pediatric Retinal Vascular Diseases: FEVR, Norrie Disease, Persistent Fetal Vascular Syndrome.Vincent Le, Gabrielle Abdelmessih, Wendy A Dailey, Cecille Pinnock, Victoria Jobczyk, Revati Rashingkar, Kimberly A Drenser, Kenneth P Mitton> ;Cells. 2023 Nov 5
- LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Tedi Begaj, Daeun Jeong, Jong G Park, Margaret M Runner, Antonio Capone Jr, A Bawa Dass, Kimberly A Drenser, Lisa J Faia, Nathan D Farley, Bruce R Garretson, Tarek S H...> ;Retina. 2024 Feb 1
- The Incidence and Timing of Treatment-Requiring Retinopathy of Prematurity in Nanopremature and Micropremature Infants in the United States: A National Multicenter Ret...Shannon D Scarboro, Clio Armitage Harper 3rd, Gopal Karsaliya, Hashem Ghoraba, Darius M Moshfeghi, Hasenin Al-Khersan, Hailey Kay Robles-Holmes, Kenneth C Fan, Audina ...> ;Ophthalmology. Retina. 2024 Mar 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Corewell Health William Beaumont University HospitalRoyal Oak, Michigan
External Links
- Associated Retinal Consultantshttp://arcpc.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: